Overview

Early Use of Hydrocortisone in Hypotensive Very Low Birth Weight Infants

Status:
Completed
Trial end date:
2010-05-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to investigate the early use of hydrocortisone in hypotensive very low birth weight infants. Based on the observations that: - hypotension is a common problem in very low birthweight infants and is associated with brain injury and poor neurological outcomes; - some infants are refractory to standard treatment (volume expansion and vasopressors), which is not exempt of adverse effects; - relative adrenal insufficiency has been described in this population; we hypothesize that hydrocortisone is effective in the treatment of hypotension in this population and reduce the need for vasopressors.
Phase:
Phase 3
Details
Lead Sponsor:
University of British Columbia
Collaborator:
BC Research Inc.
Treatments:
Antihypertensive Agents
Cortisol succinate
Hydrocortisone
Hydrocortisone 17-butyrate 21-propionate
Hydrocortisone acetate